News & Events CTI Signs Memorandum of Understanding for Strategic Partnership with Samsung Medical Center

CTI Signs Memorandum of Understanding for Strategic Partnership with Samsung Medical Center

July 15, 2019

CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization has signed a Memorandum of Understanding (MOU) with Samsung Medical Center (SMC), located in Seoul, South Korea. The purpose of the Memorandum is to affirm both CTI's and SMC's commitment to identifying and developing opportunities for cooperation and collaboration in advancing clinical research in fields such as rare and orphan disease, regenerative medicine, and hematology/oncology. The Memorandum was signed by Patrick J. Earley, CTI's Chief International Business Officer and Ki Woong Sung, Director of Clinical Research Institute at SMC. 


"We are thrilled to enter this strategic partnership with Samsung Medical Center," remarks Patrick J. Earley. "Samsung Medical Center is an innovative research site that is committed to bringing life-changing drugs to patients in need, just as CTI is. We have been working throughout the Asia-Pacific region for nearly a decade, and we have many successful collaborations throughout the region with leading academic centers and emerging biotechnology companies. CTI continues to grow steadily in the region, and we look forward to future accomplishments/efficiencies enabled by this partnership."

CTI, with an annual staff retention rate of 95%, has been working for two decades in the drug development industry across North America, Europe, South America, Pac-Asia, and Africa, specializing in clinical research programs involving critically ill patient populations, and has more than 30 offices worldwide to serve more than 200 pharmaceutical, biotechnology, and medical device clients. 

About Samsung Medical Center

When the Samsung Medical Center opened in 1994 it changed the paradigm of the domestic medical world with the advanced concepts “patient-centered” and “customer satisfaction.”

During the past 20 years, the Samsung Medical Center has received much love and encouragement and has won first place in the National Customer Satisfaction Index (NCSI) 14 times, first place in the Korean Customer Satisfaction Index (KCSI) 16 times. first place in the Korean Standard - Service Quality Index (KS-SQI) 12 times consecutively, and has been selected as the top medical center in the hospital sector in Brand Star 12 times consecutively.

In addition, the hospital in 2012 proclaimed the concepts, “Vision 2020, Happiness through Healthcare Innovation” and is making progress to become a leading hospital in the world by realizing the concept of “Happinovation 20*20”.

The Samsung Medical Center plans to achieve medical innovation in the future to promote the happiness of patients and will develop into a global hub of bio-health care study and link the industry by connecting to hospital-R&D Center-school and enterprises. At the same time, the Samsung Medical Center will create the image of a new future hospital as a public medical institution that leads social contribution.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com

Subscribe to our mailing list

* indicates required